Cargando…

Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic

OBJECTIVES: Sacral neuromodulation is an effective, minimally invasive treatment for refractory lower urinary tract dysfunction. However, regular postoperative programming is crucial for the maintenance of the curative effects of electronic sacral stimulator devices. The outbreak of coronavirus dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Lingfeng, Hou, Huimin, Zhang, Peng, Gu, Yinjun, Shi, Benkang, Li, Yan, Wang, Qingwei, Zhang, Yifei, Ren, Lijuan, Chen, Qi, Yuan, Zhen, Guo, Fan, Li, Dianyou, Ma, Yunfu, Dong, Sheng, Liu, Zhijun, Shang, Aijia, Li, Bo, Xu, Wei, Lv, Jianwei, Zhang, Yaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081490/
https://www.ncbi.nlm.nih.gov/pubmed/37035299
http://dx.doi.org/10.3389/fmed.2023.977433
_version_ 1785021136594010112
author Meng, Lingfeng
Hou, Huimin
Zhang, Peng
Gu, Yinjun
Shi, Benkang
Li, Yan
Wang, Qingwei
Zhang, Yifei
Ren, Lijuan
Chen, Qi
Yuan, Zhen
Guo, Fan
Li, Dianyou
Ma, Yunfu
Dong, Sheng
Liu, Zhijun
Shang, Aijia
Li, Bo
Xu, Wei
Lv, Jianwei
Zhang, Yaoguang
author_facet Meng, Lingfeng
Hou, Huimin
Zhang, Peng
Gu, Yinjun
Shi, Benkang
Li, Yan
Wang, Qingwei
Zhang, Yifei
Ren, Lijuan
Chen, Qi
Yuan, Zhen
Guo, Fan
Li, Dianyou
Ma, Yunfu
Dong, Sheng
Liu, Zhijun
Shang, Aijia
Li, Bo
Xu, Wei
Lv, Jianwei
Zhang, Yaoguang
author_sort Meng, Lingfeng
collection PubMed
description OBJECTIVES: Sacral neuromodulation is an effective, minimally invasive treatment for refractory lower urinary tract dysfunction. However, regular postoperative programming is crucial for the maintenance of the curative effects of electronic sacral stimulator devices. The outbreak of coronavirus disease 2019 (COVID-19) limited the ability of practitioners to perform traditional face-to-face programming of these stimulators. Therefore, this study aimed to evaluate the application of remote programming technology for sacral neuromodulation during the COVID-19 pandemic in China. MATERIALS AND METHODS: We retrospectively collected data including baseline and programming information of all patients with lower urinary tract dysfunction who underwent sacral neuromodulation remote programming in China after the outbreak of COVID-19 (i.e., December 2019). The patients also completed a self-designed telephone questionnaire on the subject. RESULTS: A total of 51 patients from 16 centers were included. They underwent 180 total remote programming visits, and 118, 2, 25, and 54 voltage, current, pulse width, and frequency adjustments, respectively, were performed. Additionally, remote switching on and off was performed 8 times; impedance test, 54 times; and stimulation contact replacement, 25 times. The demand for remote programming was the highest during the first 6 months of sacral neuromodulation (average, 2.39 times per person). In total, 36 out of the 51 patients completed the questionnaire survey. Of these, all indicated that they chose remote programming to minimize unnecessary travel because they had been affected by COVID-19. The questionnaire also showed that remote programming could reduce the number of patient visits to the hospital, save time, reduce financial costs, and would be easy for patients to master. All surveyed patients indicated that they were satisfied with remote programming and were willing to recommend it to other patients. CONCLUSION: Remote programming for sacral neuromodulation is feasible, effective, safe, and highly recommended by patients with refractory lower urinary tract dysfunction. Remote programming technology has great development and application potential in the post-pandemic era.
format Online
Article
Text
id pubmed-10081490
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100814902023-04-08 Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic Meng, Lingfeng Hou, Huimin Zhang, Peng Gu, Yinjun Shi, Benkang Li, Yan Wang, Qingwei Zhang, Yifei Ren, Lijuan Chen, Qi Yuan, Zhen Guo, Fan Li, Dianyou Ma, Yunfu Dong, Sheng Liu, Zhijun Shang, Aijia Li, Bo Xu, Wei Lv, Jianwei Zhang, Yaoguang Front Med (Lausanne) Medicine OBJECTIVES: Sacral neuromodulation is an effective, minimally invasive treatment for refractory lower urinary tract dysfunction. However, regular postoperative programming is crucial for the maintenance of the curative effects of electronic sacral stimulator devices. The outbreak of coronavirus disease 2019 (COVID-19) limited the ability of practitioners to perform traditional face-to-face programming of these stimulators. Therefore, this study aimed to evaluate the application of remote programming technology for sacral neuromodulation during the COVID-19 pandemic in China. MATERIALS AND METHODS: We retrospectively collected data including baseline and programming information of all patients with lower urinary tract dysfunction who underwent sacral neuromodulation remote programming in China after the outbreak of COVID-19 (i.e., December 2019). The patients also completed a self-designed telephone questionnaire on the subject. RESULTS: A total of 51 patients from 16 centers were included. They underwent 180 total remote programming visits, and 118, 2, 25, and 54 voltage, current, pulse width, and frequency adjustments, respectively, were performed. Additionally, remote switching on and off was performed 8 times; impedance test, 54 times; and stimulation contact replacement, 25 times. The demand for remote programming was the highest during the first 6 months of sacral neuromodulation (average, 2.39 times per person). In total, 36 out of the 51 patients completed the questionnaire survey. Of these, all indicated that they chose remote programming to minimize unnecessary travel because they had been affected by COVID-19. The questionnaire also showed that remote programming could reduce the number of patient visits to the hospital, save time, reduce financial costs, and would be easy for patients to master. All surveyed patients indicated that they were satisfied with remote programming and were willing to recommend it to other patients. CONCLUSION: Remote programming for sacral neuromodulation is feasible, effective, safe, and highly recommended by patients with refractory lower urinary tract dysfunction. Remote programming technology has great development and application potential in the post-pandemic era. Frontiers Media S.A. 2023-03-13 /pmc/articles/PMC10081490/ /pubmed/37035299 http://dx.doi.org/10.3389/fmed.2023.977433 Text en Copyright © 2023 Meng, Hou, Zhang, Gu, Shi, Li, Wang, Zhang, Ren, Chen, Yuan, Guo, Li, Ma, Dong, Liu, Shang, Li, Xu, Lv and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Meng, Lingfeng
Hou, Huimin
Zhang, Peng
Gu, Yinjun
Shi, Benkang
Li, Yan
Wang, Qingwei
Zhang, Yifei
Ren, Lijuan
Chen, Qi
Yuan, Zhen
Guo, Fan
Li, Dianyou
Ma, Yunfu
Dong, Sheng
Liu, Zhijun
Shang, Aijia
Li, Bo
Xu, Wei
Lv, Jianwei
Zhang, Yaoguang
Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
title Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
title_full Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
title_fullStr Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
title_full_unstemmed Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
title_short Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
title_sort sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: china’s experience during the covid-19 pandemic
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081490/
https://www.ncbi.nlm.nih.gov/pubmed/37035299
http://dx.doi.org/10.3389/fmed.2023.977433
work_keys_str_mv AT menglingfeng sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT houhuimin sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT zhangpeng sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT guyinjun sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT shibenkang sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT liyan sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT wangqingwei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT zhangyifei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT renlijuan sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT chenqi sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT yuanzhen sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT guofan sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT lidianyou sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT mayunfu sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT dongsheng sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT liuzhijun sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT shangaijia sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT libo sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT xuwei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT lvjianwei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic
AT zhangyaoguang sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic